AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hakki, M.
Right arrow Articles by Marr, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hakki, M.
Right arrow Articles by Marr, K. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2006, p. 2522-2524, Vol. 50, No. 7
0066-4804/06/$08.00+0     doi:10.1128/AAC.00148-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Emergence of a Candida krusei Isolate with Reduced Susceptibility to Caspofungin during Therapy

Morgan Hakki,1,2 Janet F. Staab,1 and Kieren A. Marr1,2*

Program in Infectious Diseases, Fred Hutchinson Cancer Research Center,1 Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington 981092

Received 3 February 2006/ Returned for modification 14 February 2006/ Accepted 27 April 2006

Clinical failure associated with reduced susceptibility to caspofungin has been described in Candida albicans and C. parapsilosis. We report a case of Candida krusei infection that progressed despite caspofungin therapy. Reduced microbial susceptibility to all three echinocandins (caspofungin, anidulafungin, and micafungin) was noted but was not associated with mutations in FKS1.


* Corresponding author. Mailing address: Fred Hutchinson Cancer Research Center, Program in Infectious Diseases, 1100 Fairview Ave. N., MS D3-100, Seattle, WA 98109. Phone: (206) 667-6702. Fax: (206) 667-4411. E-mail: kmarr{at}fhcrc.org.


Antimicrobial Agents and Chemotherapy, July 2006, p. 2522-2524, Vol. 50, No. 7
0066-4804/06/$08.00+0     doi:10.1128/AAC.00148-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.